Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Sex Hormone and Insulin/IGF Axes in Endometrial Cancer Recurrence

NCT01150682 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01150682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Sex Hormone and Insulin/IGF Axes in Endometrial Cancer Recurrence
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2010
Completion date
Not reported
Enrollment
865 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer